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Abstract
Background: Multiple profilin isoforms exist in mammals; at least four are expressed in the
mammalian testis. The testis-specific isoforms profilin-3 (PFN3) and profilin-4 (PFN4) may have
specialized roles in spermatogenic cells which are distinct from known functions fulfilled by the
"somatic" profilins, profilin-1 (PFN1) and profilin-2 (PFN2).
Results: Ligand interactions and spatial distributions of PFN3 and PFN4 were compared by
biochemical, molecular and immunological methods; PFN1 and PFN2 were employed as controls.
β-actin, phosphoinositides, poly-L-proline and mDia3, but not VASP, were confirmed as in vitro
interaction partners of PFN3. In parallel experiments, PFN4 bound to selected phosphoinositides
but not to poly-L-proline, proline-rich proteins, or actin. Immunofluorescence microscopy of PFN3
and PFN4 revealed distinct subcellular locations in differentiating spermatids. Both were associated
first with the acroplaxome and later with the transient manchette. Predicted 3D structures
indicated that PFN3 has the actin-binding site conserved, but retains only approximately half of the
common poly-L-proline binding site. PFN4, in comparison, has lost both, polyproline and actin
binding sites completely, which is well in line with the experimental data.
Conclusion: The testis-specific isoform PFN3 showed major hallmarks of the well characterized
"somatic" profilin isoforms, albeit with distinct binding affinities. PFN4, on the other hand, did not
interact with actin or polyproline in vitro. Rather, it seemed to be specialized for phospholipid
binding, possibly providing cellular functions which are distinct from actin dynamics regulation.

Background

Profilins are small, ≈ 14-kDa intracellular proteins which
are crucial for actin microfilament dynamics ([1-4]; for

review, see [5]). Their ubiquity, abundance, and necessity
for life in higher organisms underscore their general
importance ([6]; for review, see [7]). Despite their small
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size, their functions are amazingly diverse. Through binding to numerous protein ligands, profilins are components of complex protein networks (for review, see [8]).
Interactions with components of the phosphatidylinositol cycle [9] and the rac-rho pathway [10,11] implicate
them as a link through which the actin cytoskeleton communicates with the major signalling pathways of the cell.
Accordingly, reducing the amount of profilin protein, e.g.
by gene deletion, often has severe or even fatal consequences on the viability of the afflicted organism.
Profilins constitute a large and diverse protein family.
Multiple isoforms exist in many species, being encoded by
separate genes, or in some cases translated from mRNA
splice variants. In animals and higher plants, isoforms
may be expressed in a tissue-specific manner. Moreover,
profilins are found at different subcellular locations (for
review, see [7]). Enrichment at dynamic plasma membranes was confirmed for various cells types. Also, profilins were observed in association with internal
membranes involved in vesicular transport [12]. Finally,
profilins are constituents of the cell nucleus (for review,
see [7] and [8]). Although the overall structure is conserved, sequence homologies between profilins from different species, and also between different isoforms from
the same organism, are low ([13]; for review, see [8]). It
was, nevertheless, reported that the overall functional
properties of different profilins are similar, and that one
isoform can be interchanged with another one from quite
a distant source [14]. On the other hand, structural differences, which determine in vitro affinities for various ligands [15,16], preferential protein complex formation in
different cell types, and different subcellular locations
may be important clues of divergent, possibly non-overlapping in vivo functions of different isoforms.
Despite extensive studies, the significance of the multiple
profilins, their tissue-specificity and distinct subcellular
locations have remained enigmatic. At least four different
profilins were demonstrated to be present in the mammalian testis [17-20], a complexity which was not observed
in somatic tissues. The mammalian testis may, thus, serve
as a model to question whether profilin isoforms may fulfil distinct functions. Profilin-1 (PFN1) is ubiquitous and
essential for cell viability [6]; its expression in all cell types
of the testis, including spermatogenic cells, thus seems
obvious. In comparison, profilin-2 (PFN2) is predominantly found in the nervous system and has acquired
more specialized functions in regulating neuronal activity
[21]; it may represent a cell type-specific isoform also in
the testis. While PFN1 and PFN2 were both demonstrated
in the somatic Sertoli cells [19], a third isoform, profilin3 (PFN3), is expressed solely in spermatids [18,20]. Most
recently, profilin-4 (PFN4) was characterized as a novel
isoform. It shows less than 30% amino acid identity with
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the other mammalian profilins; still, database searches
produced significant alignments with the conserved profilin domain. PFN4 is also highly expressed during spermatogenesis, but is distinct from PFN3 in its temporal
expression pattern [20].
Based on sequence comparisons, it was speculated that
the testis-expressed PFN3 and PFN4 might have altered
binding capacities for actin and proline-rich ligands [13].
However, such diverse characteristics remained to be
experimentally shown. In the present study, using yeast
two-hybrid interaction assays and various biochemical
methods, the binding capacities of PFN3 and PFN4 for
proline-rich ligands, actin, and phosphoinositides were
studied in comparison with PFN1 and PFN2. Subcellular
locations in differentiating spermatids were studied by
immunofluorescence. Three-dimensional structural models were also built to explain the functional properties of
PFN3 and PFN4.

Results and Discussion
PFN3 and PFN4 have different in vitro affinities for
protein ligands
Actin monomers, poly-L-proline (PLP), and proline-rich
proteins have been confirmed as in vitro ligands for each
profilin isoform tested so far. In addition, in vivo interactions of various profilins have been verified with actin (for
review, see [3]), and proline-rich proteins, including the
vasodilator-stimulated phosphoprotein (VASP; [22]) and
the mammalian homologues of Drosophila diaphanous
(mDia), members of the formin gene family [23]. In analogy with this, several databases of known and predicted
protein-protein interactions suggested that the testisexpressed isoforms PFN3 and PFN4 would likewise associate with these ligands [24,25]. We asked whether PFN3
and PFN4 indeed shared these affinities.

Protein lysates containing pET-expressed ("untagged")
PFN3 and PFN4 proteins were employed in PLP affinity
chromatography. PFN3 bound to the PLP affinity column
(Figure 1A, upper panel); however, compared to PFN1
and PFN2, the association was weaker, since PFN3 was
eluted from the PLP column at 2 to 4 M urea (compare
PLP affinity chromatography data presented in [26]).
Under the same experimental conditions, PFN4 failed to
interact with PLP (Figure 1A, lower panel), suggesting that
different from the above predictions proline-rich protein
ligands may not be targets for this isoform. Since PLP
affinity chromatography is routinely employed to purify
native as well as recombinant profilins, the lack of polyproline interaction caused complications in the purification of untagged PFN4.
Selective pair wise tests for yeast two-hybrid (Y2H) interaction ("minimatings"), assaying potential differences of
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Figure 1 interaction of PFN3 and PFN4
Poly-proline
Poly-proline interaction of PFN3 and PFN4. (A) Poly-L-proline (PLP) affinity chromatography. PLP interaction of PFN3
(upper panel) and PFN4 (lower panel) was examined by column chromatography and fractions analysed on SDS gels of which
only the 14–20 kDa regions are shown. PFN3 bound to the PLP-column and was eluted by 2 M and 4 M urea (protein bands
highlightened by frame), while PFN4 failed to interact with PLP and was washed from the column during initial washing steps
(protein bands highlightened by frame). L: cell lysate before column; F: flow-through, W: wash without urea (1–9 indicate fraction numbers); E2: 2 M urea eluate; E4: 4 M urea eluate; E8: 8 M urea eluate; M: low mass ladder, Ps: pre-stained marker. (B)
Quantitative β-galactosidase assay for selective pair wise Y2H interaction of PFN2, PFN3, and PFN4 with polyproline-rich
VASP and DIAPH3. Diploids containing PFN2 and VASP or PFN2 and Diaph3 showed significant activity, reflecting the ability of
PFN2 interact with these proteins. PFN3-containing diploids revealed significant but weaker binding to DIAPH3, and no binding
to VASP. PFN4 failed to interact with both proteins. Bars show quantitative β-galactosidase activity [milliunits/(ml × cells)] of
colonies grown in SD/-LTHA (Leu- Trp- His- Adenine-) high stringency medium. The red line marks the level of the negative
control. * designates significant β-galactosidase activities. Positive control: diploids from SD/-LTHA medium containing p53
(pGBKT7–53) and SV40 large T-antigen (pGADT7-T). Negative control: diploids with HE6/GPR64-C-terminus (pGBKT7-H2121-1) und SV40 T-antigen (pGADT7-T) showing no interaction.
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PFN3 and PFN4 in their affinities for specific proline-rich
proteins, i.e. VASP and mDia3 (Figure 1B), were performed as an independent method. PFN2a, which is
known to bind VASP and p140mDia [15,22,23], was
included as a positive control. Expression of the LacZ
reporter was used as a more quantitative indicator for the
strength of protein-protein interactions. mDia3, but not
VASP, was confirmed as an in vitro binding partner of
PFN3 (Fig. 1B). The interaction of mDia3 with PFN3 was
weaker compared to PFN2a; parallel Y2H assays employing PFN4, in comparison, were negative (Figure 1B), confirming the results of the PLP affinity chromatography.
Notably, our previous microarray analyses of human testis tissue ([27] and own unpublished results) had shown
that at least five mDia3-encoding mRNAs variants, including the one employed in the Y2H assays here, were highly
expressed in the testis and were most abundant in tissue
samples, which contained post-meiotic germ cells. Thus,
mDia3 proteins may still represent in vivo interaction partners of PFN3.
Binding of the testis-specific profilin isoforms to β-actin
was similarly tested by a pair wise Y2H interaction, confirming PFN3 as an actin-binding isoform (Figure 2A).
Parallel assays employing PFN4 were all negative (Figure
2A), suggesting that neither proline-rich proteins nor
actin were targets of this unusual isoform. The failure of
PFN4 to interact with actin contrasts with all other profilins studied thus far, most of which bind actin monomers
with micromolar affinity. The Y2H method, however, is
prone to false-negative discovery. By attaching domains
from a transcription factor to the bait and prey proteins,
true interactions may be missed if fusions place these
attachments at important interacting actin and/or profilin
interfaces [28]. To confirm the Y2H results by two independent methods, co-immunoprecipitation of β-actin
and actin polymerization assays were performed. For coimmunoprecipitation PFN2, PFN3, and PFN4 were translated in vitro as N-terminal fusions to a c-myc-tag; a c-mycantibody was employed to immunoprecipitate the profilins in the presence of HA-tagged β-actin. While PFN2 and
PFN3 effectively co-precipitated with β-actin as evidenced
by their retention by protein A beads, PFN4 failed to associate with β-actin also under these experimental conditions (Figure 2B). In a control experiment, in the absence
of profilins, β-actin was not precipitated with protein A
beads (data not shown).
We probed the influence of recombinantly expressed GSTfusions of PFN3 and PFN4 on salt-induced actin polymerization using the pyrenyl fluorescence assay [29]. Labelled
skeletal muscle G-actin was incubated with or without the
purified GST-fused profilins (Figure 3). GST-PFN1, which
served as a control, showed a significant retardation of
actin polymerization. Under the same experimental con-
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ditions, PFN3 also markedly reduced polymerization
kinetics, albeit to a lesser extent. PFN4, on the other hand,
did not influence the actin polymerization kinetics at all
(Figure 3). In summary, concerning PFN3 protein interaction partners, our results confirmed and extended the
results by Hu et al. [17], suggesting that PFN3 showed
major hallmarks of the well characterized profilins. PFN4,
on the other hand, did not bind the tested protein ligands
in vitro and thus may have in vivo functions different from
regulating actin dynamics. It should be noted that spermatids contain several actin-related proteins [30].
Recently, the actin-related protein ArpM1 was identified
as an interaction partner of PFN3 [31]. The interaction of
PFN4 and actin-related proteins expressed in spermatids
deserves further evaluation.
PFN3 and PFN4 differentially interact with phospholipids
Profilins interact with anionic phospholipids ([32]; for
review, see [8]). Individual phospholipids show distinct
subcellular distributions and perform distinct biological
roles (for review, see [33]), with steady-state concentrations of PtdIns(4,5)P2 predominating at plasma membranes, PtdIns(3)P on endosomes, and PtdIns(4)P on the
Golgi. Thus, through differential binding to these phospholipids in vivo, profilin isoforms may be selectively
directed to functionally appropriate subcellular sites.
Selective interaction with phosphoinositides was indeed
the first functional difference reported between different
profilin isoforms [34,35]. Moreover, it was shown that
binding to PtdIns(4,5)P2 may effectively compete for PLP
interaction of profilin 1 [36]. More recently, neighbouring
binding sites for these competing ligands have emerged
which may explain the competing interactions [37,38].

Phospholipid interactions of GST-fusion proteins of
PFN1, PFN3, and PFN4, respectively, were assayed by protein-lipid overlay [39]. Each of the recombinant fusions
strongly bound to PtdIns(3)P, and to a lesser extent to its
phosphorylated products and PtdIns(4,5)P2 (Figure 4).
Unlike GST-PFN1 (and also other profilins), GST-PFN3
and GST-PFN4 both showed in vitro affinity towards
PtdIns(4)P, suggesting that in vivo, in addition to endosomes, PFN3 and PFN4 may be associated with the Golgi
apparatus. For GST-PFN4, a weak but reproducible binding to phosphatidic acid (PA) was additionally observed
(Figure 4). PA is an abundant component (1–4%) of most
cellular membranes. It is also a signalling lipid, since its
regulated formation can constitute an important signal for
many downstream responses, including actin polymerization in spermatozoa [40]. In addition to this role, PA
appears to regulate enzymes in phospholipase D pathways directly. The list of PA-binding proteins is rapidly
expanding (for review, see [41]); however, PA-binding of
profilins has not been previously reported. The specificity
of the observed interaction must be considered critically
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of PFN3 and PFN4 with actin
In vitro interaction of PFN3 and PFN4 with actin. A) Yeast two-hybrid (Y2H) interaction assays of PFN2, PFN3, and
PFN4 with β-actin (left panel). Plate growth assays were performed on minimal media in the absence of histidine (SD/-LTH) or
adenine (SD/-LTA) or both (SD/-LTHA). Interaction is indicated by growth of diploid colonies. Upper panel shows assay for
profilin-pGADT7 × actin-pGBKT7 on SD/-LTHA medium. Lower panel shows positive control (actin-pGBKT7 × huProfilin-2pGADT7) on the left;, negative control (actin-pGBKT7 × pGADT7) on the right. Quantification was carried out by β-galactosidase assay (right panel) using diploids from SD/-LTHA-medium Red line marks the negative value; * designates significant activities. Positive control: diploids containing p53 (pGBKT7–53) and SV40 large T-antigen (pGADT7-T). Negative control: diploids
with HE6/GPR64-C-terminus (pGBKT7-H21-21-1) und SV40 T-antigen (pGADT7-T). B) Western blot analysis of hemagglutinin epitope (HA)-tagged β-actin co-immunoprecipitated with c-myc-tagged PFN2, PFN3, and PFN4. Analyses employing the cmyc- antibody showed that the three profilin isoforms (~14 kDa) were precipitated (upper panel; highlightened by arrow).
Analyses employing the anti-HA- antibody showed that actin-HA (~45 kDa) was co-precipitated with PFN2 and PFN3, but not
with PFN4 (bottom panel; highlightened by arrow). The ~28 kDa and ~50 kDa protein bands resulted from the light and heavy
chains of the c-myc-antibody.
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as the isoelectric point of PFN4 is basic (pI 8.8); still, GSTPFN3 did not bind PA under the same experimental conditions, despite of the highly basic character of PFN3 (pI
9.5).
PFN3 and PFN4 localize in the acroplaxome-manchette
complex in spermatids
Cross-reactivity of the profilin antisera employed in
immunostaining procedures was initially studied by
Western blot analysis using in vitro translated profilins
(Figure 5A). Antisera generated against PFN3 and PFN4
did not cross-react; weak cross-reactivity of the anti-PFN3
antiserum was observed only with in vitro-translated
PFN2. In protein extracts of human adult testis tissue (Figure 5B), and also in rat testis samples collected during the
first wave of rat spermatogenesis (Figure 5C), anti-PFN3
and anti-PFN4 immunoreactive bands of ≈ 14-kDa were
seen only in those tissue samples which contained spermatids, confirming at the protein level the previously
reported stage- and cell-type specific expression patterns
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of PFN3 and PFN4 [20]. In comparison, anti-PFN1 and
PFN2 immunoreactive bands were obvious in each testis
sample analysed (Figure 5C).
Our previous studies suggested that PFN3 and PFN4 accumulated near the acrosome-acroplaxome-manchette complex of differentiating spermatids ([2]0 and data not
shown). The acroplaxome is an F-actin/keratin 5-containing cytoskeletal plate, which anchors the acrosome to the
spermatid nucleus [42]. Pro-acrosomal vesicles derived
from the Golgi apparatus [43] are transported by F-actinand microtubule-based molecular motors and dock and
fuse along the acroplaxome (for review, see [44]). The
manchette is a transient structure developed subjacent to
the marginal ring of the acroplaxome. It consists of a perinuclear ring with inserted microtubules as well as associated F-actin. The manchette participates in the transport
of cargoes to the developing spermatid tail and in nucleocytoplasmic trafficking during spermatid head shaping
[45].

Figureof3GST-tagged profilin isoforms on β-actin polymerization kinetics
Effect
Effect of GST-tagged profilin isoforms on β-actin polymerization kinetics. 5 μM actin and 15 μM each of GST-PFN1,
GST-PFN3, and GST-PFN4 were pre-incubated prior to induction of actin polymerization by addition of KCl and MgCl2. Time
courses of actin alone (red) or in the presence of GST-PFN1 (green), GST-PFN3 (blue) or GST-PFN4 (orange) are shown.
PFN1 markedly delayed actin polymerization, PFN3 influenced polymerization kinetics to a lower extent, and PFN4 had no
obvious effect.
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Indirect immunofluorescence of spermatids isolated from
spermatogenic stage-specific rat seminiferous tubules was
used to determine the localization of PFN3 and PFN4
throughout spermiogenesis. Phalloidin-Texas Red was
used to monitor the F-actin-containing acroplaxome;
tubulin monoclonal antibody was used to determine the
position of the manchette with respect to the acroplaxome. PFN3 immunoreactivity was mainly observed in the
acroplaxome of round spermatids and may be correlated
with the presence of F-actin (Figure 6/1, panels A-L). During the progression of spermiogenesis, PFN3 acroplaxome
immunoreactivity gradually disappeared and became
apparent in the developing manchette of spermatids step
8 (S8) (Figure 6/1, panels D-F). Coinciding with the initiation of manchette disassembly in S14 spermatids, PFN3
immunoreactivity was seen in the cytoplasm subjacent to
the disassembling manchette (Figure 6/1, panels G-I). At
this stage, the phalloidin-stained acroplaxome was devoid
of PFN3 (Figure 6/1, panels J-L). A similar immunoreactive staining pattern was observed with anti-PFN4 serum

http://www.biomedcentral.com/1471-2121/10/34

in rat (Figure 6/2, panels A-L) and also in human spermatids (Additional File 1). In agreement with the immunoblotting data, normal rabbit IgG controls did not generate
a fluorescence signal (data not shown). Panel M in Figure
6/2 summarizes diagrammatically the localization of
PFN3 and PFN4, first in the acroplaxome and later in the
manchette during spermatid head development. These
observations suggested that, despite their differing functional characteristics in vitro, the location sites of PFN3
and PFN4 proteins in spermatids were similar. In vivo
functions of the tissue- and cell type-restricted isoforms,
however, remain obscure. Transgenic mouse models may
help to clarify whether and how PFN3 and PFN4 impact
on acrosome formation and/or spermatid head shaping.
Structural models explain the observed biochemical
properties of PFN3 and PFN4
In order to gain a deeper understanding of the observed
functional differences, homology models were built for
human PFN3 and PFN4, and compared to the known

Figure 4 overlay assay of profilins
Protein-lipid
Protein-lipid overlay assay of profilins. Phosphoinositide (PIP) overlay assay of Glutathione-S-transferase (GST)-fusion
proteins showed selective binding of GST-PFN1, GST-PFN2, and GST-PFN4 to nitrocellulose-bound phosphoinositides (100
picomoles per spot). GST alone did not bind. PIP strips™ were incubated with 0.5 μg/ml of each fusion protein as indicated.
Layout of strips (according to Molecular Probes product information) was as follows. Spot # 1: Lysophosphatidic acid; # 2: Lysophosphatidylcholine; # 3: Phosphatidylinositol (PtdIns); # 4: PtdIns(3)P; # 5: PtdIns(4)P; # 6: PtdIns(5)P; # 7: Phosphatidylethanolamine; # 8: Phosphatidylcholine; # 9: Sphingosine 1-phosphate; # 10: PtdIns(3,4)P2; # 11: PtdIns(3,5)P2; # 12:
PtdIns(4,5)P2; #13: PtdIns(3,4,5)P3; #14: Phosphatidic acid; #15: Phosphatidylserine; #16: Blank.
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structures of human PFN1 and PFN2a. The sequence
alignments of all known human profilins are shown in
Figure 7A, and those used for modelling in additional file
2. Both PFN3 and PFN4 are predicted to be folded like
other profilins, with a central 7-stranded antiparallel betasheet covered on both faces by two alpha helices. The
PFN4 sequence, however, is ten amino acids shorter
which is structurally reflected by three loops, i.e. β1β2,
β4β5, and β5β6, being shorter in the PFN4 protein (Figure
7B). One of the loops, β5β6, is also shorter in PFN3.
The poly-L-proline binding site
The PLP binding site of profilins is formed by conserved
aromatic amino acids located in the N- and C-terminal
helices, such that the proline-rich peptide will bind to a
groove between the two helices, interacting closely with

kDa

PFN2

PFN3

the aromatic residues via hydrogen bonds and CH-pi
interactions [15,38,46]. For example, five conserved aromatic residues (Trp3, Tyr6, Trp31, Tyr133, and Phe139)
and also Asn9 are responsible for the PLP interaction of
PFN2a (Figure 6C), and PFN1 is highly similar. The two
aromatic residues on the C-terminal helix (Tyr133 and
Phe139 in PFN2a) are not present in PFN3, which could
lead to an altered specificity and/or lower affinity towards
proline-rich sequences, as also evidenced by our binding
assay. In PFN4, of the abovementioned aromatic residues,
only Tyr122 is conserved (corresponding to His133 of
PFN1 and Tyr133 of PFN2a). Thus, in this isoform, the
aromatic surface of other profilins necessary for PLP binding is not present at all, which is in line with its observed
inability to bind proline-rich sequences. While the overall
sequence of PFN4 is more similar to the profilins of lower
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Figure 5 of anti-profilin antibodies
Specificity
Specificity of anti-profilin antibodies. A) Western blot analysis of in vitro translated profilins employing antibodies directed
against PFN2 (left panel), PFN3 (middle panel), and PFN4 (right panel). Note that there is no cross-reactivity of anti-PFN3 and
anti-PFN4 antibodies. B) Western blot analysis of PFN2 (left panel), PFN3 (middle panel), and PFN-4 (right panel) protein
expression in human testes showing varying degrees of spermatogenetic failure. Lane 1: Sertoli-cell-only appearance; lane 2:
maturation arrest at meiosis; lane 3: hypospermatogenesis; lane 4: full spermatogenesis; lane 5: full spermatogenesis; lane 6: salivary gland as control. Note that PFN3 and PFN4 immunoreactive protein bands of ≈ 14 kDa were solely observed in tissue
samples containing sufficient amounts of spermatids while PFN2 was detected in each tissue analysed. C) Western blot analysis
of PFN1 and PFN2 (upper panels), PFN3 (middle panel), and PFN4 (lower panel) proteins in rat testis at various stages of postnatal development. Lane 1: day-15; lane 2: day-18; lane 3: day-20; lane 4: day-24; lane 5: day-26; lane 6: day-28; lane 7: day-30;
lane 8: day-45; lane 9: day-60 testes. Note that PFN3 and PFN4 immunoreactive protein bands of ≈ 14 kDa were solely
observed in testes at developmental stages, which contained sufficient amounts of elongating spermatids (high lightened by
arrows). PFN1 and PFN2 immunoreactive bands, in comparison, were observed at all stages analysed.
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eukaryotes than to the other human/mammalian profilins [13], PFN4 seems to be the only family member so
far, in which the entire PLP binding site is lacking, suggesting that it may have other binding partners instead.
The actin-binding site
In PFN1, residues centrally involved in actin binding
include Phe59, His119, Arg74, Arg88, Lys90, Lys125, and
Tyr128 (Figure 7D; [47]); these are fully conserved in
PFN2a. In PFN3, this site is conserved, with some rather
conservative amino acid sequence differences, such as the
replacement of Phe59 and Tyr128 by Leu59 and His125,
respectively, compared to PFN2a. These structural differences may have lowered or altered the affinity of PFN3
towards actin to some degree, when compared to PFN1
and PFN2a. In the PFN4 sequences, in contrast, there is no
conservation of the known actin-binding residues of other
profilins, which is well in line with our experimental data
described above.
The PtdIns(4,5)P2 binding site
Based on mutagenesis studies and the localisation of sulphate and phosphate ions in crystal structures, the binding site for PtdIns(4,5)P2 has been approximately mapped
in human PFN1 [37]. It involves several conserved basic
amino acid residues on the profilin surface, generating a
large binding surface of positively charged residues. In
PFN2a, residues likely to contribute to PtdIns(4,5)P2
binding include arginines 74, 88, 104, 107, and 135, and
these binding determinants are largely conserved in PFN1.
Interestingly, Arg74 and Arg135 are among the few residues, which are conserved throughout the known human
profilin isoforms, including PFN4 (Figure 7A). In PFN3,
the putative common PtdIns(4,5)P2 binding site is well
conserved. In PFN4, many basic residues are present as
well, but the putative phospholipid binding site seems to
have shifted (Figure 7E). This structural difference may
explain the distinct phospholipid binding characteristics
of PFN4 (see above).

Conclusion
We report functional differences between the testisexpressed profilins PFN3 and PFN4 as revealed by in vitro
assays. At the same time, structural homology models
were built for human PFN3 and PFN4, which explained
their different functional characteristics. By various methods, mDia3, but not VASP, was identified as a novel in
vitro binding partner of PFN3, while PFN4 did not bind
PLP or proline-rich proteins. So far, PFN4 seems to be the
only profilin family member in which the entire PLP
binding site is lacking. Moreover, different from PFN3,
PFN4 did not interact with actin in three different in vitro
assays deviating from all other profilins analysed thus far.
Actually, the structure of PFN4 does not retain the actin-
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binding site of other profilins. A much lower affinity for
actin or actin-related proteins is thus conceivable, suggesting that PFN4 may perform in vivo functions, which are
distinct from regulating actin dynamics. PFN3 and PFN4
were both capable of in vitro phosphoinositide interaction, but differed in their selectivity towards specific phospholipids. In PFN3, the putative common PtdIns(4,5)P2
binding site of profilins is conserved while it seems to
have shifted in PFN4. PFN3 and PFN4 coexist in the acroplaxome and the manchette of spermatids in a sequential
developmental manner. They vanish gradually from the
acroplaxome when the manchette fully assembles and
spermatid head shaping is in progress. Although the presence of PFN3 can be correlated with the presence of Factin and actin-related proteins in the acroplaxome, and
to a lesser extent in the manchette, the visualization of
PFN4 in the acroplaxome-manchette complex is intriguing in light of our finding that it does not interact with
actin in vitro. An F-actin independent role of PFN4 may
suggest novel functions related to the process of spermatid
head shaping, and may have significant clinical implications in understanding idiopathic causes of male infertility associated with abnormal sperm head shaping.

Methods
Tissues and spermatogenic cells
Human testis tissue was obtained surgically from patients
undergoing a testicular sperm extraction procedure (courtesy of Professor Dr. med. Wolfgang Schulze, Department
of Andrology, University Hospital Hamburg-Eppendorf,
Germany). Informed consent and Ethic Committee
Approval was obtained (OB/X/2000), and the ethical
principles for research involving human tissues as stated
in the 52nd World Medical Association Declaration of Helsinki were strictly observed. For protein extraction, tissue
samples were submerged immediately in a cryoprotectant
and snap-frozen in liquid nitrogen.

All animal housing and operation practices were in compliance with German Animal Welfare laws, and the Guiding Principles in the Care und Use of Laboratory Animals
(DHEW Publication, NIH, 80-23) were observed in all
cases. For protein extraction, male Wistar rats were
obtained from the UKE animal house. Animals were sacrificed at days 10, 15, 20, 22, 26, 28, 30, 45, and 60 (n =
10 per age group) by decapitation (5- and 10-days-old
animals) or CO2 inhalation (all others). Control tissues
were taken from 60-days-old animals. Tissues were snapfrozen in liquid nitrogen immediately after removal. For
the preparation of germ cells, adult male Sprague Dawleyrats (n = 3) were obtained from Charles River Inc. Animals
were killed by CO2-asphyxiation, the testes removed,
transferred to 32°C PBS solution and decapsulated.
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Figure 6 of profilin 3 (panels 1) and profilin 4 (panels 2) during rat spermiogenesis
Localization
Localization of profilin 3 (panels 1) and profilin 4 (panels 2) during rat spermiogenesis. 1, panels A-C: S9 spermatids display profilin 3 immunoreactivity (A) in acroplaxome (F-actin component stained with phalloidin-Texas Red) and manchette (detected with tubulin monoclonal antibody). Manchette is caudal to acroplaxome (B). Arrows in B and C indicate
tubulin immunoreactive spermatid tail. Arrowhead in C (Pha-Co microscopy: phase-contrast microscopy) points to acrosomal
granule. Apx: acroplaxome. Man: manchette. Panels D-F: S10 spermatid. Profilin 3 is predominant in manchette. Panels G-I: S14
spermatid. Profilin 3 extends into cytoplasm caudal to manchette. Panels J-L: S14 spermatid. Panel K illustrates position of acroplaxome. Note that profilin 3 is not associated with the acroplaxome but with the manchette. 2, panels A-C. Early S8 (eS8).
Profilin 4 is predominant in acroplaxome (A) at the initiation of the manchette (B). C indicates positions of acroplaxome (Apx)
and manchette (Man). Panels D-F. S14 spermatid. Profilin 4 is seen in manchette but not in acroplaxome. Panels G-I. S9 spermatid. Profilin 4 is predominant in manchette (G). Position of acroplaxome is shown in H. Note that adjacent Golgi is slightly
stained. I indicates acroplaxome (Apx), manchette (Man) and Golgi resolved by phase-contrast. Panels J-L. S14 spermatid. Profilin 4 is restricted to manchette (J) and not seen in acroplaxome (seen in K). L indicates manchette (Man) and acroplaxome
(Apx). Panel M provides diagrammatic summary (not to scale) of profilin 3 and profilin 4 localization sites during S6 to S10. The
acroplaxome is immunoreactive in S6 spermatids. Acrosomal immunoreactivity decreases in apical region in S7 spermatids preceding the onset of manchette assembly (S8). Profilin 3 and profilin 4 are predominant in the manchette of S9 and S10 spermatids. Note migration of Golgi from apical to caudal position in spermatid cytoplasm. Scale bars: 2 μm.
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Antibodies
Polyclonal rabbit antisera against synthetic peptides were
generated as described [20]. 14- and 15-mer linear oligopeptides from PFN2 and PFN3, i.e. CAYSMAKYLRDSGF and CEVGVLTGPDRHTFL, respectively, were used
as antigen (Bioscience, Göttingen, Germany; Pineda-Antibodies Service, Berlin, Germany). Other antibodies used
included a rabbit polyclonal anti-PFN1 (Novus Biologicals, Littleton, USA), rabbit anti-PFN4 peptide antiserum
[20], monoclonal anti-α-tubulin DM1A (Sigma, Munich,
Germany), monoclonal anti- actin JLA20 (Calbiochem,
Schwalbach, Germany), rabbit anti-VASP [22], goat antiGST (GE Healthcare, Freiburg, Germany) and monoclonal anti-c-myc (BD Biosciences, Heidelberg, Germany). Peroxidase-conjugated secondary antibodies were
AffiniPure Fc-fragment goat anti-rabbit IgG and AffiniPure rabbit anti-mouse IgG (H+L), respectively (both
from Jackson ImmunoResearch, Newmarket, UK). Antibodies used for immunocytochemistry are indicated
below.
Protein extraction
Tissue samples were homogenized three times for 10 s
with the UltraTurrax (Art Labortechnik, Mühlheim) in 10
mM Tris, 1 mM EDTA, 0.5 mM DTT, 50 mM NaCl, 0.4%
NP-40, 0.2% NaDOC, 0.04% SDS, Protease-inhibitorcocktail (complete mini EDTA-free, Roche), pH 7.8 (100
μl solubilisation buffer per 30 mg tissue). After 30 min of
solubilisation at 4°C on a rotating wheel, debris was
removed by centrifugation (30 min, 13000 rpm, 4°C) and
the supernatants collected. Protein concentrations were
estimated employing the BioRad Protein-Assay according
to the suggestions of the supplier (BioRad, München, Germany).
In vitro translation and co-immunoprecipitation
C-myc-tagged profilins and HA-tagged β-actin were synthesized from pGBKT-7 and pGADT-7 plasmid constructs
using the TNT®-T7 Quick Coupled Transcription, Translation System (Promega, Mannheim, Germany) according
to manufacturer's instruction. 25 μl of β-actin in vitro
translation reaction was co-incubated with 25 μl of profilin in vitro translation reaction at room temperature for 2
h. After incubation, 3 μl of anti c-myc-antibody (BD Biosciences) and 200 μl protein A-agarose (Roche Diagnostics, Penzberg, Germany) in PBS were added and the
mixtures incubated overnight at 4°C. Protein A beads
were then washed three times (10 s, 4°C, 7000 rpm) with
500 μl co-immunoprecipitation buffer containing 50 mM
Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5% NP-40.
Proteins were eluted at 95°C for 5 min in sample buffer
(40 mM Tris, pH 6.8, 2% SDS, 100 mM DTT, 1 mM EDTA,
8% glycerol). After removal of protein A beads by centrifugation, 25 μl of protein supernatant were separated on a
4–12% gradient SDS-PAGE (see below), and profilins and
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actin visualized employing c-myc monoclonal antibody
(BD Biosciences) and anti-HA-high affinity monoclonal
antibody (clone 3F10, Sigma).
Western blot analysis
Western blot analysis of in vitro translated proteins and
protein extracts was carried out by standard procedures.
Briefly, approximately 80 μg proteins per lane were separated on 4–12% NuPage®Novex Bis-Tris gradient gels
(Invitrogen, Karlsruhe, Germany) and transferred to polyvinylidene difluoride membranes (Amersham) in a discontinuous buffer system using a semi-dry blotter.
Immunodetection was carried out by blocking for 1 h in
1% Western-blocking reagent (Boehringer Mannheim,
Germany) or in 5% ECL-blocking agent when using the
ECL-Plus-system (GE Healthcare, Freiburg, Germany),
followed by incubation with the first antibody over night
at 4°C. Antibody dilutions were 1:1000 for anti-PFN1,
1:10000 for anti-PFN2, 1:700 for anti-PFN3 and 1:500 for
anti-PFN4. Antibody binding was detected either by Cy5conjugated AffiniPure goat anti-rabbit IgG or a peroxidase-conjugated AffiniPure Goat anti-rabbit IgG (both
from Jackson Immuno Research, Newmarket, UK).
Profilin expression in E. coli and PLP affinity
chromatography
2xYT with kanamycin was inoculated 1:50 from a fresh
ON culture of BL21(DE3)pLys cells harbouring the mouse
PFN3 or -4 gene under control of the bacteriophage T7promoter in the vector pET28a(+). At an OD600 of 0.5,
protein expression was initiated by adding IPTG to a final
concentration of 1 mM. After induction, the bacteria were
grown for 4 h at 42°C. Then, the cells were pelleted by
centrifugation (15 min at 6000 rpm, 4°C), resuspended
in 25 ml of lysis buffer (50 mM Tris-HCl, 10 mM NaCl, 10
mM EDTA, 1.5% TritonX-100, 1:1000 Trasylol, 1 μM Pepstatin A, 50 μM Pefabloc SC) and incubated for 20 min on
ice. After adding lysozyme, the solution was frozen overnight at -80°C. Next day, the solution was thawed at 37°C
and then sonicated on ice 10 times 30 s at 80 W probe
energy with 30-s intervals. The lysate was centrifuged at
4°C for 50 min at 14000 rpm. The supernatant was
loaded onto a poly-L-proline column, washed and equilibrated with washing buffer (20 mM Tris-HCl, 150 mM
NaCl). The column was washed with 5–10 column volumes of washing buffer and then with washing buffer
including 2 M urea, to remove unbound protein. To analyze the binding affinity, profilins were then eluted with 4
M and 8 M elution buffer (4 M/8 M Urea in washing
buffer). Fractions were collected and checked by standard
SDS-PAGE.
Yeast Two-Hybrid Interaction
Yeast strains AH109 and Y187 and pGBKT7 and pGADT7
plasmids were from the Matchmaker Two-Hybrid System 3
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Figure 7
Three-dimensional
models of PFN3 and PFN4
Three-dimensional models of PFN3 and PFN4. A. Sequence alignment between human profilins. Fully conserved residues are on dark background. Key residues of PLP binding are indicated by asterisks, those involved in binding actin with triangles. Secondary structures are derived from bovine PFN1 crystal structure. For compatibility with most publications, the first
methionine is not considered in sequence numbering. B. Superposition of bovine PFN1 (yellow), mouse PFN2a (magenta),
human PFN3 (green), and human PFN4 (cyan). PFN1 structure is from the profilactin complex (PDB core 1HLU) and PFN2a
from the complex with a VASP peptide (PDB code 2V8C). Loops variable in length in PFN3 and/or PFN4 are marked. C. Comparison of the PLP-binding sites of PFN2a, PFN3, and PFN4. Shown is also the PFN2a-VASP complex, colouring as in 6B. Only
half of the binding site is conserved in PFN3, no conservation is seen in PFN4. Key residues for peptide binding are indicated.
D. Actin-binding sites of PFN1, PFN3, and PFN4, colouring as in 6B. For clarity, actin is not shown; view is from the direction
of actin onto the actin-binding surface on profilin, side chains of key profilin residues are shown. E. Comparison of
PtdIns(4,5)P2 binding surfaces of PFN1, 2a, 3, and 4 (left to right, respectively). Profilins are coloured as in 6A, and all arginine
residues, crucial for PtdIns(4,5)P2 binding, are highlighted in blue; lysine residues are shown in gray.
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(Clontech), providing HIS3, ADE2 and lacZ reporters and
allowing high stringency assays. For bait and prey construction from human and mouse testes cDNAs, oligodeoxynucleotide primers as given in table 1 were employed
in RT-PCR amplification and amplicons subcloned into
the multiple cloning site of pGBKT7 and pGADT7 vectors.
The coding region of the human VASP cDNA was likewise
subcloned into pGADT7 and pGBKT7. The yeast strains
were transformed with the constructs ([48]; Quick and
Easy Transformation Protocol) and colonies grown according to the Yeast Protocols Handbook (Clontech, Heidelberg,
2001). Plasmid selection was maintained by growing cells
in minimal medium (0.67% yeast nitrogen base, 2% glucose) supplemented with lysine, histidine, adenine and
tryptophan (for pGADT7 selection) or leucine (for
pGBKT7 selection). Mating tests were performed under
conditions of increasing stringency according to the manufacturer's suggestions. Diploid colonies were replicaplated on minimal medium with high stringency and
grown at 30°C for 4–8 days. Colonies were isolated and
tested for the expression of the lacZ reporter using the βGalactosidase Assay Kit (Pierce). Prey plasmids were isolated, transformed into Escherichia coli, and inserts verified
by sequence analysis (MWG). Interactions were verified
by plate growth assays on minimal mediums in the
absence of histidine or adenine or both.
Actin polymerization assay
Muscle actin was purified from rabbit skeletal muscle as
described [49] and labelled with pyrene according to
Kouyama and Mihashi [29]. Recombinant profilins were
expressed as glutathion-S transferase (GST) fusion proteins in Escherichia coli ER2566 (New England Biolabs,
Heidelberg, Germany) and purified by glutathione sepharose affinity chromatography according to the manufacturer's instructions (GE Healthcare). Eluted profilins were
dialysed against 20 mM Tris-Cl, pH 7.4, 0.2 mM CaCl2, 1
mM dithiothreitol and stored on ice. To determine their
influence on actin polymerization, 5 μM α-actin (5%
pyrene-labelled) in G-buffer (2 mM Tris-HCl, pH 7.5, 0.2
mM ATP, 0.1 mM CaCl2, 0.5 mM DTT) was incubated for
10 min at 20°C with or without 15 μM recombinant GSTfused profilins. Polymerization was initiated by the addition of MgCl2 and KCl (final concentration 1 mM and 50
mM, respectively). Fluorescence was monitored for 2 h at
366 nm excitation and 407 nm emission using a LS50B
fluorimeter (Perkin Elmer, Langen, Germany).
Protein-lipid overlay assay
PIP Strips™ membranes (Molecular Probes, Eugene, USA)
were employed following the manufacturer's instructions.
Briefly, after blocking with 3% bovine serum albumin
(BSA) in TBS-T (10 mM Tris-Cl, ph 8.0, 150 mM NaCl,
0.1% (v/v) Tween 20) the lipid-containing membranes
were incubated with 0.5 μg/ml GST fused profilins for 2.5
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h. Membranes were washed three times with TBS-T + 3%
BSA and the bound proteins detected by anti-GST antibody in conjunction with HRP-labelled secondary antibody and enhanced chemiluminescence.
Immunofluorescence microscopy
Spermatogenic cells were collected from mechanically dissociated seminiferous tubular fragments (identified with a
dissecting stereomicroscope as corresponding to stages IXIV of rat spermatogenesis according to their transillumination pattern). Cells were placed in a drop of 3.7% paraformaldehyde (electron microscopy grade) in 0.1 M
sucrose in phosphate buffer, pH 7.4, on microscope slides
coated with Vectabond (Vector Laboratories, Burlingame,
CA). This fixation procedure results in the preservation of
the
Golgi-acrosome-acroplaxome-manchette-nuclear
relationship in spermatids, a condition that facilitates
structure identification and access of antigenic probes.
After 15-min fixation at room temperatures a coverglass
was placed on top of the preparation. The glass coverslip
was removed and the microscope slide- containing fixed
spermatogenic cells was used for immunocytochemistry
(see below). Cells were immunoreacted with affinity purified PFN3 and PFN4 (working dilution: 1:200) and αtubulin monoclonal antibody (working dilution 1:100;
Sigma-Aldrich, St. Louis, MO), followed by anti-rabbit
IgG-conjugated with fluorescein isothiocyanate or antimouse IgG conjugated with rhodamine (working dilution
1:200; Jackson Immunoresearch Laboratories, West
Grove, PA), respectively. Phalloidin-Texas Red-X was used
to detect F-actin according to the manufacturer's protocol
(Molecular Probes, Eugene, OR). Specimens were
mounted with Vectashield (Vector Laboratories) and
examined in a Zeiss Universal phase-contrast/fluorescence microscope equipped with episcopic illumination.
Images were recorded using a Magnafire digital CCD camera (Optronics, Goleta CA).
Generation of 3-dimensional models
Homology models for both PFN3 and PFN4 from mouse
and man were generated using the SWISS-MODEL server
[50], based on the closest sequence homologues found
from the PDB for each protein. For PFN3, the model is
based on bovine profilin 1 (PDB entry 1PNE) [51], and
for PFN4, the template was Acanthamoeba profilin II
(PDB entry 2ACG) [35]. The structures were superimposed with each other and profilins 1 and 2 using the SSM
method [52] in Coot [53]. Protein structure figures were
generated using Pymol, Dino, and POV-Ray.

Abbreviations
The abbreviations used are: A: Adenine; BSA: bovine
serum albumin; CCD: charge-coupled device; DTT: Dithiothreitol; EDTA: ethylenediaminetetraacetic acid; ELISA:
enzyme-linked immunosorbent assay; FITC: fluorescein
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Table 1: Primers employed in RT-PCR

Primer

Tm

product

Accession-No.

5'-CAGTGAATTCATGGCCGGT TGGCAGAG-3'
5'-CGATGGATCCAGCAGCTAGAACCCAGAGTC-3'

68°C
71°C

446 bp
ORF
(bp 99 → 526)

huProfilin2a
NM_053024

5'-TTGAATTCATGAGTGACTGGAAGGGCTACA-3'
5'-TTGGATCCGTTCACGGTTTATTCTGGTCTCC-3'

65°C
68°C

467 bp
ORF
(bp 59 → 524)

mProfilin3
NM_029303

5'-CAGTGAATTCAGCATGAGTCACTTGCG-3'
5'-GATGGATCCTTAGTTTCCCTTTTTCCTTAG-3'

63°C
64°C

405 bp
ORF
(bp 861 → 1250)

mProfilin 4
NM_028376

5'-AGTGAATTCGGGAACATGAGCCATT-3'
5'-GATGGATCCCTCTGATGACTTAACTTCCT-3'

61°C
65°C

406 bp
ORF (bp171 → 557)

huProfilin4
BC029523

5'-TAGAATTCATGGATGGATGATATCGCCGCGC-3'
5'-AAGGATCCAAGCCATGCCAATCTCA-3'

67°C
70°C

1236 bp
ORF (bp74 → 1282)

hu β-actin,
NM_001101

5'-CAGTGAATTCTTTACCGACCACCAAGAAACTCAG-3'
5'-CGATGGATCCTCATATGGCACCCGAAAAGAGC-3'

68°C 668 bp, FH1 + part. FH2-domain (bp904 → 1551)
71°C

isothiocyanate; GST: glutathione S-transferase; H: Histidine; HRP: horse reddish peroxidase; L: Leucin; mDia3:
mammalian homologue of Drosophila diaphanous, isoform 3; OD: optical density; ON: Over night; PA: phosphatidic acid; PBS: phosphate-buffered saline; PFN:
profilin; Pha-Co: phase contrast; pI: isoelectric point; PLP:
poly-L-proline; PRD: proline-rich domain; PtdIns(4,5)P2:
Phosphatidylinositol 4,5-bisphosphate; PtdIns(3)P:
Phosphatidylinositol 3-Phosphate; PtdIns(4)P: Phosphatidylinositol 4-Phosphate; SD: single dropout (synthetic minimal medium); T: Thymidin; TBS-T: Trisbuffered saline with Tween-20; VASP: vasodilator-stimulated phosphoprotein; Y2H: Yeast two-hybrid.
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Additional material
Additional File 1
Immunolocalization of PFN4-related protein in spermatids and testicular spermatozoa isolated from human testis. A1-A3) and B1-B3)
show dual labelling and confocal microscopy of human round and elongating spermatids employing indirect PFN4 immunofluorescence (green)
and PNA lectin binding (red); nuclei were stained with DAPI (dark
blue). A4 and B4 show corresponding phase contrast image. Note PFN4
immunofluorescence in acroplaxome and manchette (high lightened by
yellow arrows); spermatocyte shows weak cytoplasmic staining. Scale bars
correspond to 5 μm. C1–C3 and D1–D3 show dual labelling and confocal
microscopy of human testicular spermatozoa employing indirect PFN4
immunofluorescence (green) and PNA lectin binding (red); nuclei were
stained with DAPI (dark blue). C4 and D4 show corresponding phase
contrast image. Scale bars correspond to 20 μm and 5 μm, respectively.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712121-10-34-S1.pdf]

Additional File 2
Sequence alignments for homology modeling. A. Sequence alignment
used for the generation of the human PFN3 model. B. Sequence alignment for making the human PFN4 model.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712121-10-34-S2.jpeg]
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